Access to Distribution Network To Accelerate The Beverage Expert’s EU Expansion Plans
Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc., (CSE: BEV) (Q: BVNNF) (FSE: 7BC) (“BevCanna” or the “Company”) is pleased to announce that it has entered into a definitive share exchange agreement with Exceler Holdings Ltd. (“Exceler”), an arm’s length private British Columbia corporation. The agreement holds that BevCanna will acquire all of the issued and outstanding shares of Exceler as consideration for the issuance of two million BevCanna shares.
The agreement with Exceler will provide BevCanna with access to Exceler’s significant number of distribution points across Europe and Asia as BevCanna launches its CBD beverage products in the European Union market. BevCanna will leverage their existing joint venture with European distributor Mota Ventures, announced on Feburary 16, 2020, to execute on the Exceler agreement.
“On closing, the ability to sell through Exceler’s extensive distribution network is intended to quickly accelerate our expansion into the EU market,” said John Campbell, Chief Strategy Officer at BevCanna. “We anticipate that the BevCanna lines of CBD beverages will soon be available to consumers across the continent.”
Terms of the Agreement
Closing of the definitive agreement is subject to standard closing conditions in addition to Exceler having positive working capital and no long-term debt. No finder’s fees are payable in connection with the proposed acquisition.
None of the securities to be issued in connection with the acquisition will be registered under the United States Securities Act of 1933, as amended (the “1933 Act“), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.
About BevCanna Enterprises Inc.
BevCanna Enterprises Inc. (CSE: BEV, Q:BVNNF, FSE:7BC) develops and manufactures cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 292-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 210M bottles per annum.
Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company, including the statements regarding the expectations that the Company will close the proposed acquisition, the belief that the acquisition will provide the Company with a significant number of distribution points in Europe, the anticipated launch of the Company’s CBD products in Europe, that closing of the acquisition will accelerate expansion plans in Europe, and that the Company’s CBD products will soon be available in Europe. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include: adverse market conditions; the inability to close the acquisition for any reason; changes in regulatory or licensing requirements and timelines; ability of the Company to leverage Exceler’s contacts and distribution network, and other factors beyond the control of the parties. Investors are cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information contained in this news release.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2020/17/c5058.html
For media enquiries or interviews, please contact: Wynn Theriault, Thirty Dash Communications, 416-710-3370, email@example.com; For investor inquiries, please contact: Luca Leone, BevCanna Enterprises Inc., 604-880-6618, firstname.lastname@example.orgCopyright CNW Group 2020
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).